Examqo › Examqo library › Radiology › Abdominal imaging · IMLE
Focal liver lesions: haemangioma, FNH, adenoma, HCC and metastases
The enhancement pattern diagnoses most liver lesions: haemangioma — peripheral nodules filling inward, FNH — uniform arterial enhancement with a central scar, HCC in a cirrhotic liver — arterial enhancement and washout, and metastases — mostly hypovascular.
Why it matters in the exam
Haemangioma is the commonest solid benign liver tumour. On US — echogenic and well defined; on CT and MRI — discontinuous peripheral nodular enhancement filling inward (centripetal fill-in) and following the blood pool in every phase; very bright on T2. FNH — in a young woman: strong uniform arterial enhancement, a central scar bright on T2 that enhances late, and isodensity to liver in later phases; with hepatobiliary agent (gadoxetate) it stays bright or iso to liver. Hepatocellular adenoma — a woman on the pill, anabolic steroids or glycogen storage disease; risk of bleeding and malignant transformation; dark in the hepatobiliary phase; the HNF1α subtype loses signal on opposed phase because of intracellular fat. Adenoma above 5 cm — resection.
HCC: in a cirrhotic liver or with HBV it can be diagnosed without biopsy. LI-RADS defines major features: enhancement in the late arterial phase (non-rim), washout in the portal or delayed phase, an enhancing capsule and threshold growth. A lesion of 10 mm or more with these features by the size rules is LR-5 — definite HCC. A liver CT or MRI needs at least a late arterial phase, a portal venous phase and a delayed phase. Surveillance in cirrhosis: US every 6 months, with or without AFP. Fibrolamellar HCC — a young patient without cirrhosis, a large mass with a central scar dark on T2 and calcified (unlike the bright scar of FNH).
Metastases: most are hypovascular (colon and gastrointestinal tract) and appear dark in the portal phase and as a "target" on US — a target lesion in the liver is usually a metastasis. Hypervascular metastases: NET, kidney, melanoma, thyroid. Calcified metastases: mucinous colorectal tumours. DWI detects small metastases that are otherwise missed. Cysts: simple cyst — anechoic without enhancement; hydatid cyst — daughter cysts, a detached membrane ("water lily") and a calcified wall; pyogenic abscess — a "cluster" of small cysts coalescing. Biliary hamartomas (von Meyenburg) — many tiny cysts very bright on T2 without biliary communication. Liver lymphoma — multiple hypoechoic lesions.
Key points
- Haemangioma — fills from the edge inward.
- FNH — uniform arterial with a bright scar.
- Adenoma — pill, bleeding, resect above 5 cm.
- HCC — arterial enhancement and washout in cirrhosis.
- Metastases — mostly hypovascular, target lesion.
Summary table
| Lesion | Enhancement pattern | MRI | Key word |
|---|---|---|---|
| Haemangioma | Peripheral nodules filling inward | Very bright on T2 | Follows the blood pool |
| FNH | Uniform arterial, iso to liver later | Scar bright on T2; stays bright in the hepatobiliary phase | Young woman, no treatment needed |
| Adenoma | Arterial, sometimes heterogeneous | Dark in the hepatobiliary phase; intracellular fat | Pill, bleeding, resect above 5 cm |
| HCC | Arterial enhancement and washout, capsule | LI-RADS 5 | Cirrhosis or HBV |
| Metastasis | Hypovascular in most cases | DWI sensitive | Target lesion on US |
Free exam questions
לאיזה מהוורידים הבאים מתנקז דם מ- caudate lobe ?של כבד (the question as examined, in Hebrew)
- א. Right hepatic vein
- ב. Left hepatic vein
- ג. Middle hepatic vein
- ד. Inferior vena cava
בן 30 , חולץ אחרי שרגלו נמעכה מתחת לפלטה כבדה שנפלה במפעל בו הוא עובד. בקבלתו למלר"ד עדות במוניטור ל- peaked T wave. מה?ו השלב הבא בניהול המקרה (the question as examined, in Hebrew)
- א. SL Aspirin 100mg
- ב. IV 50ml D50W+10 units insulin
- ג. IV Furosemide 80mg
- ד. SC Clexane 1mg/kg
איזה מהבאים נכון בנוגע לשימוש במרקרים סרטניים כבדיקות סקר? (the question as examined, in Hebrew)
- א. CEA נמצא שימושי לבדיקת סקר, אך לא נמצא בקשר להישרדות
- ב. PSA נמצא שימושי לבדיקת סקר ולרוב מתנרמל תוך חודש אחרי רדיותרפיה
- ג. AFP לא משמש לבדיקת סקר ואף אינו נמצא בקורולציה לגודל הגידול ולפרוגנוזה
- ד. CA 19-9 לא משמש לבדיקת סקר, אך נמצא בקורלציה לעומס המחלה ולפרוגנוזה
In the full version for subscribers
- A simple algorithm
- Memory aid
- Exam traps
- 5 review cards
- Enough for IMLE
The full version is open to subscribers of: Diagnostic radiology, Medical licensing exam (IMLE), Internal medicine, General surgery.
Subscriber? Read the full topic Plans and prices 25 free questions
Sources
- ACR LI-RADS CT/MRI Core, version 2018 — Major features and categories
- EASL Clinical Practice Guidelines on the Management of Benign Liver Tumours, 2016 — Haemangioma, FNH and hepatocellular adenoma
- AASLD Practice Guidance on Prevention, Diagnosis and Treatment of Hepatocellular Carcinoma, 2023 — Surveillance and non-invasive diagnosis
Sources are given for further reading; the text is written afresh and not copied from them.
Reviewed by the Examqo AI Professor · 2026-11-06. The text may contain errors; when in doubt, check the source.